Retatrutide is a triple agonist that activates GLP-1, GIP, and glucagon receptors, whereas semaglutide targets only GLP-1 and tirzepatide targets GLP-1 and GIP
10.1111/dom.13120 [DOI] [PMC free article] [PubMed] [Google Scholar] 192.Meier JJ, Rosenstock J, Hincelin-Mry A, Roy-Duval C, Delfolie A, Coester HV, et al
Husain KH, et al
Here's a realistic timeline: Mild Strain (Grade 1) Standard recovery : 3-4 weeks With BPC-157 : 2-3 weeks Improvement : ~30-40% faster Moderate Sprain (Grade 2) Standard recovery : 6-8 weeks With BPC-157 : 4-5 weeks Improvement : ~35-40% faster Severe Tear (Grade 3) or Post-Surgical Standard recovery : 12-16 weeks With BPC-157 : 8-10 weeks Improvement : ~35-40% faster Note : These are generalizations
Shuqiang M, Kunzheng W, Xiaoqiang D, Wei W, Mingyu Z, Daocheng W
perfringens ) treated vector control extracts, indicating reduced sialylation of IGF-1R in GNE knockdown cells (Fig